decreased cerebral cortex pyramidal cell number_Kat6b<Gt(pKC199)1Pgr>/Kat6b<Gt(pKC199)1Pgr>

http://metadb.riken.jp/0009974I129Kat6bGtpKC1991PgrKat6bGtpKC1991PgrKat6bGtpKC1991Pgr

decreased cerebral cortex pyramidal cell number_Kat6b<Gt(pKC199)1Pgr>/Kat6b<Gt(pKC199)1Pgr>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• K(lysine) acetyltransferase 6B
  http://metadb.riken.jp/db/mgi_rdf/MGI:1858746

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Kat6b<Gt(pKC199)1Pgr>/Kat6b<Gt(pKC199)1Pgr>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Kat6b<Gt(pKC199)1Pgr>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased cerebral cortex pyramidal cell number
  http://purl.obolibrary.org/obo/MP_0009974

文献

http://purl.org/net/cito/citesAsAuthority

• Michael. Kraft, et.al., Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice., The Journal of clinical investigation, 2011, 121
  http://rdf.ncbi.nlm.nih.gov/pubmed/21804188